Delivery Order SPE2DB20D3103-SPE2DB25FP5Q2
Award Date 7/18/25
Potential Completion Date 8/8/25
Potential Value $8.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,829.81 firm fixed-price delivery order is for the supply of 300-unit/mL doses of HYPERRAB, a rabies immunoglobulin product. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This delivery order is a component of Amerisourcebergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,895.75 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. The contract, which was competitively awarded with no set-aside designation, is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 300 unit/mL vials of HYPERRAB, a rabies immune globulin product. The contract has a ceiling value of $4,653.68 and a completion date of January 13, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medication used to treat rabies exposure. The contract has a firm fixed price of $9,391.75 and an ultimate completion date of August 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,391.75 Firm Fixed Price Delivery Order contract is for the supply of 5 mL vials of HYPERRAB 300 UNIT/ML, a rabies immunoglobulin product. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.81 firm fixed price contract is for the delivery of IMOVAX Rabies Vaccine Vials. The ultimate completion date is January 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.75 firm fixed-price delivery order is for IMOVAX Rabies Vaccine Vials and has a completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a $42,818.03 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of rabies vaccine. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to...
- This is a delivery order (Contract #SPE2DB22D3004|SPE2DB23FQB95) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a rabies immunoglobulin product, with a ceiling value of $7,971.51 and a period of performance through May 9, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,031.44 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a specialized rabies medication. The contract has an ultimate completion date of November 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...